Skip to content

Clinical evaluation of effects of Hijama- Bila- Shurt (Dry Cupping) as a part of multimodal approach in the management of fibromyalgia.

Clinical evaluation of effects of Hijama- Bila- Shurt (Dry Cupping) as a part of multimodal approach in the management of fibromyalgia.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046928
Enrollment
60
Registered
2022-10-31
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M797- Fibromyalgia

Interventions

Intervention1: Dry cupping and Habbe Asgandh: Intervention group A: â?¢ Application of Dry Cupping (Hijamah Bila Shurt) once in a week on tender points for 10 minutes for total of 4 weeks. Intervent

Sponsors

Ajmal Khan Tibbiya College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Clinically Diagnosed patient of FMS (Based on 2016 revision of American College of Rheumatology (ACR) Diagnostic Criteria of 2011/2010. 2. Patients who are able to give written informed consent and follow the protocol of study. 3. Patients of either sex 4. Patients in age group of 20-60 years.

Exclusion criteria

Exclusion criteria: 1. Patients below 20 years and above 60 years 2. Primary generalized osteoarthritis, polymyalgia rheumatica, Rheumatoid arthritis, Diabetic Neuropathy,Hypothyroidism Pregnant and Lactating women 4. Patients with uncontrolled diabetes and severe hypertension. 5. Patient taking medicine for any other psycho- somatic disorders. 6. History of trauma. 7. Patients having anemia(Hb% less than 9gm%). 8. Patients unable to give informed written consent.

Design outcomes

Primary

MeasureTime frame
Improvement Criteria- it will be correlated with the subjective and objective parameters. 1.Primary Parameters â?¢ NRS (Numeric Rating Scale) 0-no pain to 10-worst possible pain Timepoint: Every 14th day for 28 days

Secondary

MeasureTime frame
2. Secondary Parameters: 1.Revised Fibromyalgia Impact Questionaire(FIQR) 2.Requirement of acetaminophen(650mg) on weekly basis. Timepoint: Every 14th day for 28 days

Countries

India

Contacts

Public ContactSUMAYYA PARVEZ

Department of Ilaj bit tadbeer Ajmal khan Tibbiya college Aligarh Muslim University Aligarh

mohdanwarnium@gmail.com8979224254

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026